...
首页> 外文期刊>Pulmonary pharmacology & therapeutics >Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma - An exploratory study
【24h】

Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma - An exploratory study

机译:倍氯米松/福莫特罗和布地奈德/福莫特罗固定组合对轻度至中度哮喘患者肺功能和气道炎症的影响-一项探索性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Rationale: Asthma is a chronic inflammatory airway disease of the whole bronchial tree. In this exploratory study we investigated the effects of beclomethasone/formoterol (becl/form) and budesonide/ formoterol (bud/form) fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma.Methods: 22 adult patients with asthma (mean FEV1 91.6% pred.) were recruited to this prospective phase IV, double-blind, double-dummy, two-way cross-over, single-centre, randomised study. After a 7 days run-in period with bud 200 ug bid patients were randomised to receive 4 weeks of becl/form (100/ 6 mug) bid in a pressurised metered dose inhaler or bud /form (160/4.5 ug) bid administered via dry powder inhaler. We measured spirornetry, bodyplethysmography, impulse oscillometry, nitric oxide (NO) and its alveolar fraction (C_AlV), and assessed sputum cellularity.
机译:理由:哮喘是整个支气管树的一种慢性炎症性气道疾病。在这项探索性研究中,我们研究了倍氯米松/福莫特罗(becl / form)和布地奈德/福莫特罗(bud / form)固定组合对轻度至中度哮喘患者肺功能和气道炎症的影响。方法:22例成年哮喘(平均FEV1为91.6%之前)被纳入该前瞻性IV期,双盲,双虚拟,双向交叉,单中心,随机研究。经过7天的芽期磨合期后,将200 ug出价的患者随机接受4周becl / form(100/6杯)出价的加压计量吸入器或通过/给药的bud / form(160 / 4.5 ug)出价干粉吸入器。我们测量了呼吸,人体体积描记术,脉冲示波法,一氧化氮(NO)及其肺泡分数(C_AlV),并评估了痰的细胞性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号